Skip to content

Clinical trials

Phase 2 Squamous Cell Carcinoma of Head and Neck trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 2 Country / region: United Kingdom Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20121
20131
20152
20161
20172
20182
20196
20202
20218
20222
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated8
Active, not recruiting6
Unknown status3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ALX Oncology Inc.2
European Organisation for Research and Treatment of Cancer - EORTC2
Gilead Sciences2
ISA Pharmaceuticals2
Kura Oncology, Inc.2
Merck Sharp & Dohme LLC2
Seagen Inc.2
AstraZeneca1
Bayer1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck35
Head and Neck Neoplasms14
Carcinoma, Non-Small-Cell Lung6
Esophageal Squamous Cell Carcinoma3
Melanoma3
Recurrence3
Carcinoma, Squamous Cell2
Neoplasm Metastasis2
Neoplasms2
Prostatic Neoplasms2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.